Currently, the production and distribution of tirzepatide custom peptides is primarily handled by a select few pharmaceutical giants. Merck & Co. stands out as one of the foremost manufacturers in the United States, with a significant commitment to research and development in this area. Furthermore, companies like Boehringer Ingelheim are actively